Analogues of key precursors of aspartyl protease inhibitors: Synthesis of trifluoromethyl amino epoxides

Journal of Organic Chemistry

Volumn 70, Issue 2, 2005, Pages 699-702

  Nguyen, Thi Ngoc Tam ^a   Magueur, Guillaume ^a   Ourévitch, Michèle ^a   Crousse, Benoit ^a   Bégué, Jean Pierre ^a   Bonnet Delpon, Danièle ^a  

^a UNIVERSITÉ PARIS SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADDITION REACTIONS; AMINES; CHEMICAL ACTIVATION; ETHERS; MAGNESIUM COMPOUNDS; STEREOCHEMISTRY; SUBSTITUTION REACTIONS; SYNTHESIS (CHEMICAL);

ASPARTYL PROTEASE INHIBITORS; BROMHYDRINS; PRECURSORS; VINYLMAGNESIUM BROMIDE;

ENZYME INHIBITION;

BROMINE DERIVATIVE; ETHER DERIVATIVE; UNCLASSIFIED DRUG; VINYLMAGNESIUM BROMIDE;

ADDITION REACTION; ALLYLATION; ARTICLE; CYCLIZATION; STEREOCHEMISTRY;

AMINES; ASPARTIC ENDOPEPTIDASES; ENZYME INHIBITORS; EPOXY COMPOUNDS; MOLECULAR STRUCTURE; PRODRUGS; STEREOISOMERISM;

EID: 12344252565     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0485233     Document Type: Article

References (52)

1. (a) Leung, D.; Abbenante, G.; Fairlie, D. P. J. Med. Chem. 2000, 43, 305-341.
2. (b) James, M. N. G., Ed. Advances in Experimental Medicine and Biology; 1998; Vol. 436.
3. (c) Takahashi, K., Ed. Advances in Experimental Medicine and Biology; 1995; Vol. 362.
4. (a) Babine, R. E.; Bender, S. L. Chem. Rev. 1997, 97, 1359-1472.
5. (b) Seife, C. Science 1997, 277, 1602-1603.
6. (c) Craik, M. S.; Debouck, C. Perspect. Drug Discovery Des. 1995, 2, 1-125.
7. (d) Wlodawer, A.; Erickson, J. W. Annu. Rev. Biochem. 1993, 62, 543-585.
8. (a) Haque, T. S.; Skillman, A. G.; Lee, C. E.; Habashita, H.; Gluzman, I. Y.; Ewing, T. J. A.; Goldberg, D. E.; Kuntz, I. D.; Ellman, J. A. J. Med. Chem. 1999, 42, 1428-1440.
9. (b) Mineno, T.; Avery, M. A. Chemstracts - Org. Chem. 2001, 14, 518-523.
10. (c) Dahlgren, A.; Kvarnström, I.; Vrang, L.; Hamelink, E.; Hallberg, A.; Rosenquist, A.; Samuelsson, B. Bioorg. Med. Chem. 2003, 11, 827-841.
11. (d) Nöteberg, D.; Hamelink, E.; Hultén, J.; Wahlgren, M.; Vrang, L.; Samuelsson, B.; Hallberg, A. J. Med. Chem. 2003, 46, 734-746.
12. See for example: (a) Parkes, K. E. B.; Bushnell, D. J.; Crackett, P. H.; Dunsdon, S. J.; Freeman, A. C.; Gunn, M. P.; Hopkins, R. A.; Lambert, R. W.; Martin, J. A.; Merret, J. H.; Redshaw, S.; Spurden, W. C.; Thomas, G. J. J. Org. Chem. 1994, 59, 3656-3664. (b) Brånalt, J.; Kvarnström, I.; Classon, B.; Samuelsson, B.; Nillroth, U.; Helena Danielson, U.; Karlén, A.; Hallberg, A. Tetrahedron Lett. 1997, 38, 3483-3486. (c) Beaulieu, P. L.; Wernic D. J. Org. Chem. 1996, 61, 3635-3645. (d) Ghosh, A. K; Hussain, K. A.; Fidanze, S. J. Org. Chem. 1997, 62, 6080-6082. (e) Ma, D.; Zou, B.; Zhu, W.; Xu H. Tetrahedron Lett. 2002, 43, 8511-8513. (f) Badorrey, R.; Cativiela, C.; Díaz-de-Villegas, M. D.; Gálvez, J. A. Tetrahedron 2002, 58, 341-354.
13. See for example: (a) Parkes, K. E. B.; Bushnell, D. J.; Crackett, P. H.; Dunsdon, S. J.; Freeman, A. C.; Gunn, M. P.; Hopkins, R. A.; Lambert, R. W.; Martin, J. A.; Merret, J. H.; Redshaw, S.; Spurden, W. C.; Thomas, G. J. J. Org. Chem. 1994, 59, 3656-3664. (b) Brånalt, J.; Kvarnström, I.; Classon, B.; Samuelsson, B.; Nillroth, U.; Helena Danielson, U.; Karlén, A.; Hallberg, A. Tetrahedron Lett. 1997, 38, 3483-3486. (c) Beaulieu, P. L.; Wernic D. J. Org. Chem. 1996, 61, 3635-3645. (d) Ghosh, A. K; Hussain, K. A.; Fidanze, S. J. Org. Chem. 1997, 62, 6080-6082. (e) Ma, D.; Zou, B.; Zhu, W.; Xu H. Tetrahedron Lett. 2002, 43, 8511-8513. (f) Badorrey, R.; Cativiela, C.; Díaz-de-Villegas, M. D.; Gálvez, J. A. Tetrahedron 2002, 58, 341-354.
14. See for example: (a) Parkes, K. E. B.; Bushnell, D. J.; Crackett, P. H.; Dunsdon, S. J.; Freeman, A. C.; Gunn, M. P.; Hopkins, R. A.; Lambert, R. W.; Martin, J. A.; Merret, J. H.; Redshaw, S.; Spurden, W. C.; Thomas, G. J. J. Org. Chem. 1994, 59, 3656-3664. (b) Brånalt, J.; Kvarnström, I.; Classon, B.; Samuelsson, B.; Nillroth, U.; Helena Danielson, U.; Karlén, A.; Hallberg, A. Tetrahedron Lett. 1997, 38, 3483-3486. (c) Beaulieu, P. L.; Wernic D. J. Org. Chem. 1996, 61, 3635-3645. (d) Ghosh, A. K; Hussain, K. A.; Fidanze, S. J. Org. Chem. 1997, 62, 6080-6082. (e) Ma, D.; Zou, B.; Zhu, W.; Xu H. Tetrahedron Lett. 2002, 43, 8511-8513. (f) Badorrey, R.; Cativiela, C.; Díaz-de-Villegas, M. D.; Gálvez, J. A. Tetrahedron 2002, 58, 341-354.
15. See for example: (a) Parkes, K. E. B.; Bushnell, D. J.; Crackett, P. H.; Dunsdon, S. J.; Freeman, A. C.; Gunn, M. P.; Hopkins, R. A.; Lambert, R. W.; Martin, J. A.; Merret, J. H.; Redshaw, S.; Spurden, W. C.; Thomas, G. J. J. Org. Chem. 1994, 59, 3656-3664. (b) Brånalt, J.; Kvarnström, I.; Classon, B.; Samuelsson, B.; Nillroth, U.; Helena Danielson, U.; Karlén, A.; Hallberg, A. Tetrahedron Lett. 1997, 38, 3483-3486. (c) Beaulieu, P. L.; Wernic D. J. Org. Chem. 1996, 61, 3635-3645. (d) Ghosh, A. K; Hussain, K. A.; Fidanze, S. J. Org. Chem. 1997, 62, 6080-6082. (e) Ma, D.; Zou, B.; Zhu, W.; Xu H. Tetrahedron Lett. 2002, 43, 8511-8513. (f) Badorrey, R.; Cativiela, C.; Díaz-de-Villegas, M. D.; Gálvez, J. A. Tetrahedron 2002, 58, 341-354.
16. See for example: (a) Parkes, K. E. B.; Bushnell, D. J.; Crackett, P. H.; Dunsdon, S. J.; Freeman, A. C.; Gunn, M. P.; Hopkins, R. A.; Lambert, R. W.; Martin, J. A.; Merret, J. H.; Redshaw, S.; Spurden, W. C.; Thomas, G. J. J. Org. Chem. 1994, 59, 3656-3664. (b) Brånalt, J.; Kvarnström, I.; Classon, B.; Samuelsson, B.; Nillroth, U.; Helena Danielson, U.; Karlén, A.; Hallberg, A. Tetrahedron Lett. 1997, 38, 3483-3486. (c) Beaulieu, P. L.; Wernic D. J. Org. Chem. 1996, 61, 3635-3645. (d) Ghosh, A. K; Hussain, K. A.; Fidanze, S. J. Org. Chem. 1997, 62, 6080-6082. (e) Ma, D.; Zou, B.; Zhu, W.; Xu H. Tetrahedron Lett. 2002, 43, 8511-8513. (f) Badorrey, R.; Cativiela, C.; Díaz-de-Villegas, M. D.; Gálvez, J. A. Tetrahedron 2002, 58, 341-354.
17. See for example: (a) Parkes, K. E. B.; Bushnell, D. J.; Crackett, P. H.; Dunsdon, S. J.; Freeman, A. C.; Gunn, M. P.; Hopkins, R. A.; Lambert, R. W.; Martin, J. A.; Merret, J. H.; Redshaw, S.; Spurden, W. C.; Thomas, G. J. J. Org. Chem. 1994, 59, 3656-3664. (b) Brånalt, J.; Kvarnström, I.; Classon, B.; Samuelsson, B.; Nillroth, U.; Helena Danielson, U.; Karlén, A.; Hallberg, A. Tetrahedron Lett. 1997, 38, 3483-3486. (c) Beaulieu, P. L.; Wernic D. J. Org. Chem. 1996, 61, 3635-3645. (d) Ghosh, A. K; Hussain, K. A.; Fidanze, S. J. Org. Chem. 1997, 62, 6080-6082. (e) Ma, D.; Zou, B.; Zhu, W.; Xu H. Tetrahedron Lett. 2002, 43, 8511-8513. (f) Badorrey, R.; Cativiela, C.; Díaz-de-Villegas, M. D.; Gálvez, J. A. Tetrahedron 2002, 58, 341-354.
18. (a) Organofluorine Compounds in Medicinal Chemistry and Biochemical Applications; Filler, R., Kobayashi, Y., Yagupolski, L., Eds.; Elsevier: Amsterdam, 1993.
19. (b) Biomedical Frontiers of Fluorine Chemistry; Ojima, I., McCarthy, J. R., Welch, J. T., Eds.; American Chemical Society: Washington, DC, 1996.
20. (c) Edwards, P. N. In Use of Fluorine in Chemotherapy. In Organofluorine Chemistry: Principles and Commercial Applications; Banks, R. E., Tatlow, J. C., Eds.; Plenum Press: New York, 1994; p 501.
21. (a) Fluorine-Containing Amino Acids, Synthesis and Properties; Kukhar, V. P., Soloshonok, V. A., Eds.; Wiley: Chichester, 1994.
22. (b) Asymmetric Fluoroorganic Chemistry: Synthesis, Applications, and Future Directions; Ramachandran, P. V., Ed.; ACS Symposium Series 746; American Chemical Society: Washington, DC, 2000.
23. Abouabdellah, A.; Bégué, J. P.; Bonnet-Delpon, D.; Kornilov, A.; Rodrigues, I.; Than Nga, T. T. In Asymmetric Fluoroorganic Chemistry; ACS Symposium Series 746; American Chemical Society: Washington, DC, 2000; Chapter 7.
24. (a) Park, B. K.; Kitteringham, N. R. Drug Metabolism Rev. 1994, 26, 605-643.
25. (b) Irurre, J.; Casas, J.; Messeguer, A. Bioorg. Med. Chem. Lett. 1993, 3, 179-182.
26. (c) Miller, J. A.; Coleman, M. C.; Matthews, R. S. J. Org. Chem. 1993, 58, 2637-2639.
27. Ojima, I.; Kato, K.; Jameison, F. A.; Conway, J.; Nakahashi, K.; Hagiwara, M.; Miyama, T. Bioorg. Med. Chem. Lett. 1992, 2, 219-222.
28. Patel, D. V.; Rielly-Gauvin, K.; Ryono, D. E.; Free, C. A.; Smith, S. A.; Petrillo, E. W., Jr. J. Med. Chem. 1993, 36, 2431-2447.
29. Sham, H. L.; Schirlin, D. In Biomedical Frontiers of Fluorine Chemistry; Ojima, I., McCarthy, J. R., Welch, J. T., Eds.; American Chemical Society: Washington, DC, 1996.
30. (a) Ojima, I.; Kuduk, S. D.; Chakravarty, S.; Ourévitch, M.; Bégué, J. P. J. Am. Chem. Soc. 1997, 119, 5519-5527.
31. (b) Ojima, I.; Slater, J. C.; Veith, J. P.; Abouabdellah, A.; Bégué, J. P.; Bernacki, R. J. Bioorg. Med. Chem. Lett. 1997, 7, 133-138.
32. (c) Myers, A. G.; Barbay, J. K.; Zhong, B. J. Am. Chem. Soc. 2001, 123, 7207-7219.
33. (d) Imperiali, B.; Abeles, R. H. Biochemistry 1986, 25, 3760.
34. (e) Sani, M.; Bruché, L.; Chiva, G.; Fustero, S.; Piera, J.; Volontario, A.; Zanda, M. Angew. Chem., Int. Ed. 2003, 42, 2060-2063.
35. (f) Pesenti, C.; Arnone, A.; Bellosta, S.; Bravo, P.; Canavesi, M.; Corradi, E.; Frigerio, M.; Meille, S. V.; Monetti, M.; Panzeri, W.; Viani, F.; Venturini, R.; Zanda, M. Tetrahedron 2001, 57, 6511-6522.
36. Abouabdellah, A.; Bégué, J. P.; Bonnet-Delpon, D.; Thanh Nga, T. T. J. Org. Chem. 1997, 62, 8826-8833.
37. Bégué, J. P.; Bonnet-Delpon, D.; Allain, L.; Thanh Nga, T. T. Unpublished results.
38. Weygand, F.; Steglich, W.; Pietta, P. Chem. Ber. 1967, 100, 3841-3849.
39. Langlois, B. R.; Billard, T. Synthesis 2003, 2, 185-194.
40. (a) Prakash, G. K. S.; Mandal, M.; Olah, G. A. Org. Lett. 2001, 3, 2847-2850.
41. (b) Kumadaki, I.; Jonoshita, S.; Harada, A.; Omote, M.; Ando, A. J. Fluorine Chem. 1999, 97, 61-63.
42. (c) Nelson, D. W.; Owens, J.; Hiraldo, D. J. Org. Chem. 2001, 66, 2572-2582.
43. Fustero, S.; Garcia Soler, J.; Bartolomé, A.; Sanchez Rosello, M. Org. Lett. 2003, 5, 2707-2710.
44. Badorrey, R.; Cativiela, C.; Díaz-de-Villegas, M. D.; Díez, R.; Gálvez, J. A. Eur. J. Org. Chem. 2003, 2268-2275.
45. Epoxidation reaction from nonprotected amine 5a with mCPBA was attempted but afforded a mixture of products.
46. Agami, C.; Couty, F. Tetrahedron 2002, 58, 2701-2724.
47. (a) Bongini, A.; Cardillo, G.; Orena, M.; Sandri, S.; Tomasini, C. J. Chem. Soc., Perkin Trans. 1 1985, 935-939.
48. (b) Rozners, E.; Liu, Y. Org. Lett. 2003, 5, 181-184.
49. (c) Blot, V.; Reboul, V.; Metzner, P. J. Org. Chem. 2004, 69, 1196-1201.
50. Legros, J.; Meyer, F.; Coliboeuf, M.; Crousse, B.; Bonnet-Delpon, D.; Bégué, J. P J. Org. Chem. 2003, 68, 6444-6446.
51. See the ORTEP view in Supporting Information. The authors have deposited atomic coordinates for 9c with the Cambridge Crystallographic Data Centre (CCDC 230713). Copies of data can be obtained via the Internet at www.ccdc.cam.ac.uk/ conts/retrieving.html (or 12 Union Road, Cambridge CB2 1EZ, UK, fax: +44-(0)223336033, e-mail: deposit@ccdc.cam.ac.uk).
52. Yanada, R.; Negoro, N.; Okaniwa, M.; Ibuka, T. Tetrahedron 1999, 55, 13947-13956.